Dr. Daniel Wahl is a physician-scientist and tenured Associate Professor of Radiation Oncology and Neurosurgery at the University of Michigan, where he specializes in cancers of the central nervous system. He earned his MD and PhD from the University of Michigan in 2012, studying Chemical Biology and immunometabolism under Drs. Gary Glick and Jamie Ferrara, then completed his radiation oncology training and a postdoctoral fellowship in brain tumor biology, metabolism, and the DNA damage response under Dr. Theodore Lawrence. In the clinic, he cares for patients with malignant and benign tumors of the central nervous system.

Dr. Wahl's laboratory studies the relationship between abnormal metabolism and therapy resistance in glioblastoma and other aggressive brain tumors, including diffuse intrinsic pontine glioma. His team has discovered numerous mechanistic links between altered metabolism, DNA repair, and treatment resistance, and has translated this work into clinical studies using stable isotope tracing and therapeutic trials. His research has been published in leading journals such as the Journal of Clinical Oncology, Cancer Discovery, Nature Communications, and Science Translational Medicine, and funded by the NCI and NINDS. He has received numerous honors, including an ASCO Young Investigator Award, a Damon Runyon Clinical Investigator Award, a Sontag Foundation Distinguished Scientist Award, and an Emerging Leader Award from the Ben and Cathy Ivy Glioblastoma Foundation, and has been named a Senior Scholar by the Forbes Institute and an Emerging Scholar by the Taubman Institute.